Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Caroline van den Ende, Cinzia Marano, Ayla van Ahee, Eveline M. Bunge & Laurence De Moerlooze. (2017) The immunogenicity of GSK’s recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience. Expert Review of Vaccines 16:8, pages 789-809.
Read now
Read now
Giovanna Zanoni, Giovanna Contreas, Enrico Valletta, Oretta Gabrielli, Carlo Mengoli & Dino Veneri. (2015) Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease. Human Vaccines & Immunotherapeutics 11:1, pages 58-62.
Read now
Read now
Heba Elrashidy, Gamal El-Didamony, Ashraf Elbahrawy, Alaa Hashim, Ahmed Alashker, Mohamed Hanafy Morsy, Ahmed Elwassief, Amr Elmestikawy, Abdallah Mahmoud Abdallah, Abdel-Gawad Saeid Mohammad, Mohamed Mostafa, Nilly M George & Hafez Abdelhafeez. (2014) Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Human Vaccines & Immunotherapeutics 10:8, pages 2336-2341.
Read now
Read now
Heba Elrashidy, Ashraf Elbahrawy, Gamal El-Didamony, Mohamed Mostafa, Nilly M George, Ahmed Elwassief, Abdel-Gawad Saeid Mohamed, Amr Elmestikawy, Mohamed Hanafy Morsy, Alaa Hashim & Mohamed Ali Abdelbasseer. (2013) Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Human Vaccines & Immunotherapeutics 9:9, pages 2002-2006.
Read now
Read now
Articles from other publishers (17)
Francesca SILVESTRI, Valeria TROMBA, Ines MAZZOTTA & Francesco COSTANTINO. (2023) How does diabetes type 1 affects immune response to hepatitis B virus vaccine in pediatric population? Evaluation of a booster dose in unresponsive subjects with type 1 diabetes. Minerva Pediatrics 75:6.
Crossref
Crossref
Amir‐Babak Sioofy‐Khojine, Jussi P. Lehtonen, Noora Nurminen, Jutta E. Laiho, Jorma Toppari, Riitta Veijola, Johanna Lempainen, Jorma Ilonen, Mikael Knip & Heikki Hyöty. (2023) HLA‐DQ‐conferred risk for type 1 diabetes does not alter neutralizing antibody response to a widely used enterovirus vaccine, the poliovirus vaccine. Journal of Medical Virology 95:4.
Crossref
Crossref
Alshymaa A. Hassnine, Mona A. Saber, Yasser M Fouad, Hatem Sarhan, Mahmoud MA Elsayed, Zaki M Zaki, Ehab M Abdelraheem, Safaa M Abdelhalim & Amr M. Elsayed. (2023) Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt. Virus Research 323, pages 198953.
Crossref
Crossref
Ming-Hui Hung, Ya-Chih Tien & Ying-Ming Chiu. (2021) Risk factors for losing hepatitis B virus surface antibody in patients with HBV surface antigen negative/surface antibody positive serostatus receiving biologic disease-modifying anti-rheumatic drugs: a nested case-control study. Advances in Rheumatology 61:1.
Crossref
Crossref
Susanna Esposito, Elena Mariotti Zani, Lisa Torelli, Sara Scavone, Maddalena Petraroli, Viviana Patianna, Barbara Predieri, Lorenzo Iughetti & Nicola Principi. (2021) Childhood Vaccinations and Type 1 Diabetes. Frontiers in Immunology 12.
Crossref
Crossref
Muammer BÜYÜKİNAN & Muhammed Yaşar KILINÇ. (2021) TİP 1 DİYABETES MELLİTUS TANILI ÇOCUKLARDA HEPATİT A VE B SEROPREVALANSIHEPATITIS A AND B SEROPREVALENCES IN CHILDREN WITH TYPE 1 DIABETES MELLITUS. Kocatepe Tıp Dergisi 22:1, pages 57-63.
Crossref
Crossref
Helal F Hetta, Nahla M Elsherbiny, Esraa M Eloseily, Samaher F Taha, Eman Fathalla Gad, Mona M Soliman, Ghada A Mohamed, Ragaa H Salama & Azza Abo Elfadl. (2020) Evaluation of the immune memory response to routine HBV vaccine in Egyptian patients with Type 1 diabetes. Future Virology 15:4, pages 215-222.
Crossref
Crossref
FarinaM Hanif, Nasir Mehmood, Zain Majid, NasirH Luck, SMudassir Laeeq, AbbasA Tasneem & MuhammadManzoor ul Haque. (2020) Successful response of intradermal hepatitis B vaccine in nonresponders of intramuscular hepatitis B vaccine in general and hemodialysis population. Saudi Journal of Gastroenterology 26:6, pages 306.
Crossref
Crossref
Muammer BÜYÜKİNAN & Muhammet Yaşar KILINÇ. (2019) Tip 1 Diabetes Mellitus Tanılı Çocuklarda Hepatit A ve Hepatit B Seroprevalansı. Zeynep Kamil Tıp Bülteni.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2019) Factors That Influence the Immune Response to Vaccination. Clinical Microbiology Reviews 32:2.
Crossref
Crossref
Raffaella Mormile. (2017) Hepatitis B vaccine non response: A predictor of latent autoimmunity?. Medical Hypotheses 104, pages 45-47.
Crossref
Crossref
Zerrin Onal, Atilla Ersen, Elvan Bayramoglu, Selcen Yaroglu Kazancı, Hasan Onal & Erdal Adal. (2016) Seroprotection status of hepatitis B and measles vaccines in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 29:9.
Crossref
Crossref
Johannes Sollner. 2016. Vaccine Design. Vaccine Design
107
130
.
Or Kalchiem-Dekel, Daniel Grupel, Lea Bouchnik, Emanuel Sikuler & Gil Ben-Yakov. (2015) Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel. Journal of Gastroenterology and Hepatology 30:12, pages 1782-1787.
Crossref
Crossref
Salvatore Leonardi, Martina Filippelli, Sara Manti, Caterina Cuppari & Carmelo Salpietro. (2015) Extending the Debate on Poor Response to Hepatitis B Virus Vaccination in Children With Celiac Disease: Which Question Remains?. Hepatitis Monthly 15:10.
Crossref
Crossref
Roohangiz Nashibi, Seyed Mohammad Alavi, Farid Yousefi, Shokrolah Salmanzadeh, Sassan Moogahi, Fatemeh Ahmadi & Mehdi Farashahinejad. (2015) Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff. Jundishapur Journal of Microbiology 8:3.
Crossref
Crossref
Martina Filippelli. (2014) Hepatitis B vaccine by intradermal route in non responder patients: An update. World Journal of Gastroenterology 20:30, pages 10383.
Crossref
Crossref